Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.
Reimann P, Mavroeidi IA, Burghofer J, Taghizadeh H, Webersinke G, Kasper S, Schreil G, Morariu D, Reichinger A, Baba HA, Kirchweger P, Schuler M, Djanani A, Prager GW, Rumpold H, Benda M, Schneider EM, Mink S, Winder T, Doleschal B. Reimann P, et al. Among authors: mavroeidi ia. Cancer Immunol Immunother. 2024 Oct 3;73(12):251. doi: 10.1007/s00262-024-03842-y. Cancer Immunol Immunother. 2024. PMID: 39358611 Free PMC article.
Theranostics with somatostatin receptor antagonists in SCLC: Correlation of 68Ga-SSO120 PET with immunohistochemistry and survival.
Mavroeidi IA, Romanowicz A, Haake T, Wienker J, Metzenmacher M, Darwiche K, Oezkan F, Bölükbas S, Stuschke M, Umutlu L, Opitz M, Nader M, Hamacher R, Siveke J, Winantea J, Fendler WP, Wiesweg M, Eberhardt WEE, Herrmann K, Theegarten D, Schuler M, Hautzel H, Kersting D. Mavroeidi IA, et al. Theranostics. 2024 Aug 26;14(14):5400-5412. doi: 10.7150/thno.98819. eCollection 2024. Theranostics. 2024. PMID: 39310095 Free PMC article.
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity.
Mavroeidi IA, Burghofer J, Kalbourtzis S, Taghizadeh H, Webersinke G, Piringer G, Kasper S, Schreil G, Liffers ST, Reichinger A, Kirchweger P, Heibl S, Hamacher R, Schmitt CA, Schuler M, Prager GW, Kersting D, Treckmann J, Schildhaus HU, Rumpold H, Siveke JT, Doleschal B. Mavroeidi IA, et al. ESMO Open. 2024 Aug;9(8):103630. doi: 10.1016/j.esmoop.2024.103630. Epub 2024 Jul 16. ESMO Open. 2024. PMID: 39018588 Free PMC article.
68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy.
Lanzafame H, Mavroeidi IA, Pabst KM, Desaulniers M, Ingenwerth M, Hirmas N, Kessler L, Nader M, Bartel T, Leyser S, Barbato F, Schuler M, Bauer S, Siveke JT, Herrmann K, Hamacher R, Fendler WP. Lanzafame H, et al. Among authors: mavroeidi ia. J Nucl Med. 2024 Jun 3;65(6):880-887. doi: 10.2967/jnumed.123.267248. J Nucl Med. 2024. PMID: 38724279
Gastroesophageal Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Scheck MK, Ekmekciu I, Sommerhäuser G, Heise C, Mavroeidi IA, Kunzmann V, Wege H, Reinacher-Schick A, Hofheinz RD, Oliver Götze T, Lorenzen S, Nieto AE. Scheck MK, et al. Among authors: mavroeidi ia. Oncol Res Treat. 2024;47(5):224-228. doi: 10.1159/000538324. Epub 2024 Mar 13. Oncol Res Treat. 2024. PMID: 38479362 Free article. No abstract available.
Colorectal Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Ekmekciu I, Nieto AE, Scheck MK, Heise C, Mavroeidi IA, Kunzmann V, Götze TO, Wege H, Reinacher-Schick A, Lorenzen S, Hofheinz RD, Sommerhäuser G. Ekmekciu I, et al. Among authors: mavroeidi ia. Oncol Res Treat. 2024;47(5):229-232. doi: 10.1159/000538110. Epub 2024 Mar 1. Oncol Res Treat. 2024. PMID: 38432226 Free article. No abstract available.
Pancreatic, Hepatic, and Biliary Tract Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2023.
Heise C, Nieto AE, Scheck MK, Ekmekciu I, Sommerhäuser G, Reinacher-Schick A, Hofheinz RD, Lorenzen S, Wege H, Kunzmann V, Götze TO, Mavroeidi IA. Heise C, et al. Among authors: mavroeidi ia. Oncol Res Treat. 2024;47(5):233-237. doi: 10.1159/000537935. Epub 2024 Feb 22. Oncol Res Treat. 2024. PMID: 38387453 Free article. No abstract available.
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor.
Hamacher R, Pabst KM, Cheung PF, Heilig CE, Hüllein J, Liffers ST, Borchert S, Costa PF, Schaarschmidt BM, Kessler L, Miera MA, Droste M, Akbulut M, Falkenhorst J, Zarrad F, Kostbade K, Mavroeidi IA, Glimm H, Umutlu L, Schuler M, Hübschmann D, Bauer S, Fröhling S, Herrmann K, Siveke JT, Schildhaus HU, Fendler WP. Hamacher R, et al. Among authors: mavroeidi ia. J Nucl Med. 2024 Feb 1;65(2):252-257. doi: 10.2967/jnumed.123.266411. J Nucl Med. 2024. PMID: 38176718
Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma.
Hamacher R, Lanzafame H, Mavroeidi IA, Pabst KM, Kessler L, Cheung PF, Bauer S, Herrmann K, Schildhaus HU, Siveke JT, Fendler WP. Hamacher R, et al. Among authors: mavroeidi ia. PET Clin. 2023 Jul;18(3):361-367. doi: 10.1016/j.cpet.2023.02.008. Epub 2023 Mar 28. PET Clin. 2023. PMID: 36997366 Review.
16 results